Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

Ozempic breasts refer to changes in breast size or shape due to weight loss from GLP-1 drugs. Here’s how and why this side ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

A common supplement may reduce a person's risk of stroke and osteoporosis, and could even help ward off dementia. A 2023 ...